Thymosin Beta-4 vs TB-500 — Peptide Comparison
Thymosin Beta-4 vs TB-500 — Peptide Comparison Thymosin Beta-4 vs TB-500 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymosin Beta-4 2–5 mg TB-500 Frequency Twice wee
This comparison does not assign a generated winner or score.
Thymosin Beta-4 vs TB-500 — Peptide Comparison Thymosin Beta-4 vs TB-500 — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range Thymosin Beta-4 2–5 mg TB-500 Frequency Twice weekly Administration Subcutaneous injection Cycle Length 8-12 weeks 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy Wound Healing Inflammation Reduction Tissue Regeneration Healing Speed Tissue Repair Anti-Scarring Technical Data Molecular Formula C212H350N56O78S Molecular Weight 4963 Half-Life Dose-dependent (increases with higher doses) Bioavailability 100% (subcutaneous and intravenous) CAS Number 77591-33-4 C38H68N10O14 889.01 g/mol 2-3 days (systemic) High via subcutaneous injection (~100%) 885340-08-9 Protocols standard 2-5 mg (community injectable practice for 'TB-500') Once or twice weekly 4-6 week loading phase, then weekly maintenance Documented community/research-practice injectable dosing for tissue repair; thymosin beta-4 has ~100% bioavailability by the subcutaneous route [1]. Not an FDA-approved use. 0.1% (1 mg/mL) RGN-259 solution, 1 drop Several times daily (e.g. up to 5x/day) 4 weeks 0.1% RGN-259 ophthalmic solution used in phase III neurotrophic keratopathy and dry-eye trials, applied as eye drops several times daily for ~4 weeks [5]. advanced 450-1200 mg IV push daily for the first 3 days, then weekly Total of 7 doses over ~5 weeks Doses studied in the RGN-352 acute myocardial infarction clinical program, given IV after PCI [6]. starting 2-2.5 mg Loading phase, 4-6 weeks Research peptide with no human trials of the fragment; loading doses used in practice [6]. Once weekly Maintenance after loading Maintenance dose used in practice following the loading phase [6]. Applications Post-Surgery Recovery Accelerates healing of surgical wounds and reduces post-operative inflammation and scarring Chronic Wound Management Helps pressure ulcers, venous stasis ulcers, and other slow-healing wounds progress faster Supports repair of damaged tissues from injury, burns, or degenerative conditions Athletes Recovering from Muscle Injuries If you've pulled a hamstring, strained your back, or torn a muscle, TB-500 helps accelerate the healing process by promoting cell migration to the injury site and supporting new blood vessel growth. It's especially useful for injuries that just won't seem to fully heal. Tendon and Ligament Problems Tendons and ligaments are notoriously slow healers because they have poor blood supply. TB-500 promotes angiogenesis (new blood vessel formation) and helps repair these stubborn connective tissue injuries—think Achilles tendonitis, tennis elbow, or rotator cuff issues. Post-Surgical Recovery After surgery, your body needs to repair a lot of tissue quickly. TB-500 supports wound healing, reduces inflammation, and may help minimize scar tissue formation. Some protocols use it alongside traditional recovery to potentially speed up the healing timeline. Chronic Inflammation and Slow Healers Some people just heal slowly—whether due to age, diabetes, or other factors. TB-500 helps regulate the inflammatory response and promotes the cellular processes needed for tissue repair. It essentially tells your body to focus healing resources where they're needed most. Safety Profile Common Injection site redness Injection site swelling Uncommon Temporary mild headache Mild bruising at injection site Transient fatigue Serious Allergic reaction Mild fatigue or lethargy Mild headache Slight flushing Head rush or lightheadedness Temporary nausea Research Status FDA Status Research compound Safety Overview Thymosin Beta-4 is a naturally occurring peptide found in all cells and body fluids in the human body. Clinical trials have demonstrated excellent safety even at very high doses. IV studies showed doses up to 1260 mg were well tolerated with no serious adverse events. Contraindications xActive systemic infections xSevere immunosuppression xHypersensitivity to thymosin or any component xPregnancy (insufficient safety data) TB-500 has shown a good safety profile across preclinical studies and limited human research. It's a fragment of thymosin beta-4, a naturally occurring protein in your body involved in healing. Most side effects are mild and transient, primarily injection site reactions. However, large-scale clinical trials are still needed to fully establish its safety profile in humans. xPregnancy or planning to become pregnant xCurrently breastfeeding xActive cancer or history of cancer xKnown allergy to peptide components xChildren and adolescents Decision Guide Choose Thymosin Beta-4 if... Recovering from injuries or surgery Improving wound healing speed Reducing inflammation Minimizing scar formation Choose TB-500 if... Accelerating injury recovery Tendon and ligament healing Reducing chronic inflammation Post-surgical recovery support